James Emigh Net Worth & Insider Trades

James Emigh - VP Corporate Development, Acura Pharmaceuticals, Inc

As of December 18, 2017

What is James Emigh's Net Worth?

The current estimated net worth of Acura Pharmaceuticals, Inc's VP Corporate Development, James Emigh, is estimated to be about $195.95K . James Emigh owns about 439,660 units of Acura Pharmaceuticals, Inc common stock. In the last 9 years at Acura Pharmaceuticals, Inc, James Emigh has sold an estimated value of $14.64K worth.

What is James Emigh's Past Insider Trading?

James Emigh's largest purchase order was 400,000 units , worth over $40K on December 18, 2017. In total, James Emigh has made about 12 transactions over 9 years of their time at Acura Pharmaceuticals, Inc. James Emigh usually trades in January, with the busiest year in 2017, 2014, 2012, 2013 and 2011.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Acura Pharmaceuticals, Inc's Past Insider Trades?

Acura Pharmaceuticals, Inc's most recent insider trade came on January 2, 2018 by Claudius Llc, International Partners Galen III, Galen Employee Fund Iii Lp, Galen Management Llc and Partners Galen III who sold 2,195,734 units worth $219.57K . In the last 9 years, insiders at Acura Pharmaceuticals, Inc have sold an estimated value of $25.32M and bought an estimated value of $15.01M worth of shares. Insider trading is most common in January, with the busiest year in 2013. The most active traders at the company are Care Capital Ii Llc,  Care Capital Investments Ii Lp,  and Care Capital Offshore Investments Ii Lp .

ACURA PHARMACEUTICALS, INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1